Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:23 PM
Ignite Modification Date:
2025-12-24 @ 2:23 PM
NCT ID:
NCT05825859
Eligibility Criteria:
Inclusion Criteria:
* Documented history of chest pain with CT imaging showing a potential for obstructive coronary artery disease
* Ability to sustain adenosine injection 0.14 mg/kg/min
Exclusion Criteria:
* Second or third degree AV-block without pacemaker
* Sick sinus syndrome
* Consumption of coffee or aminophylline within 12 hours of administration
* Recent use of dipyridmole or dipyridamole-containing medications
* Known hypersensitivity to adenosine
* Unstable acute MI or acute coronary artery syndrome, and prior cardiac transplantation
* Active wheezing and bronchospasm
* Sinus bradycardia with HR\<40 bmp
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05825859
Study Brief:
Protocol Section:
NCT05825859